A nurse is caring for a client with diabetic nephropathy who has developed chronic kidney disease stage 4. Which nursing intervention should be the priority?

Blood pressure control is the most critical intervention for clients with diabetic nephropathy and chronic kidney disease stage 4. Hypertension accelerates kidney damage and cardiovascular complications. ACE inhibitors or ARBs are typically prescribed to protect kidney function and control blood pressure.

Diabetic nephropathy is a serious complication of diabetes that progresses through five stages, with stage 4 indicating chronic kidney disease where the glomerular filtration rate is severely reduced to 15-29 mL/min/1.73m². At this advanced stage, the priority nursing intervention is blood pressure management, because hypertension is both a cause and a consequence of diabetic nephropathy.

Pathophysiologically, chronic hyperglycemia causes damage to the glomerular capillaries, increasing permeability and leading to protein loss. This damage activates the renin-angiotensin-aldosterone system, resulting in hypertension. Uncontrolled blood pressure further accelerates kidney damage through increased glomerular pressure and sclerosis.

Blood pressure control using ACE inhibitors or ARBs is especially essential because these medications not only lower blood pressure but also reduce intraglomerular pressure and proteinuria, providing a kidney-protective effect. The target blood pressure for patients with diabetic nephropathy is generally less than 130/80 mmHg.

This intervention is a priority because it directly addresses the primary mechanism of disease progression and helps prevent cardiovascular complications, which are the leading cause of death in patients with diabetic nephropathy. Early and aggressive blood pressure management can slow the progression to end-stage renal failure and reduce mortality.

Understanding the Priority in Diabetic Nephropathy with CKD Stage 4

The central pathophysiological concern in a client with diabetic nephropathy who has progressed to chronic kidney disease (CKD) stage 4 is the aggressive preservation of remaining renal function and the mitigation of cardiovascular risk, which is the leading cause of death in this population. The priority nursing intervention is therefore to monitor blood pressure closely and administer antihypertensive medications as prescribed.

Pathophysiology and Rationale for Blood Pressure Control
In CKD, hypertension is both a cause and a consequence of declining kidney function. The mechanisms are multifactorial, driven by volume overload due to impaired sodium and water excretion, pathological activation of the renin-angiotensin-aldosterone system (RAAS), increased sympathetic nervous system activity, and progressive vascular dysfunction ^[4]. Uncontrolled hypertension transmits elevated intraglomerular pressure, which mechanically damages the already fragile glomerular basement membrane, directly accelerating the loss of nephrons. This creates a vicious cycle where hypertension worsens CKD, and worsening CKD further elevates blood pressure. Tight blood pressure control is the single most effective strategy to slow the progression of renal disease and reduce the substantial cardiovascular morbidity associated with it ^[3][4]. In clinical practice, this involves not only accurate and frequent monitoring but also the administration of RAAS-blocking agents, such as ACE inhibitors or ARBs, which have a specific renoprotective effect beyond their blood pressure-lowering capability ^[4].

Analysis of Incorrect Options

- Option 2: Encourage increased protein intake to maintain nutritional status. This intervention is contraindicated. While nutritional support is crucial for patients on maintenance hemodialysis to combat inflammation and malnutrition, as evidenced by improved serum creatinine and nutritional indicators with targeted support , the strategy is different in pre-dialysis CKD stage 4. A high-protein diet increases intraglomerular pressure and the kidneys' solute load, which can accelerate the decline in renal function. The goal in this stage is typically controlled, not increased, protein intake to reduce renal workload.

- Option 3: Administer insulin only when blood glucose exceeds 200 mg/dL. This approach is incorrect and dangerous. The underlying cause of the nephropathy is diabetes, and strict glycemic control is foundational to preventing further microvascular damage, including to the renal capillaries. A sliding-scale insulin regimen that only treats hyperglycemia after it occurs fails to provide the consistent basal glucose control needed to minimize the formation of advanced glycation end products (AGEs) that contribute to glomerular injury. The goal is to maintain blood glucose as close to the normal range as is safely possible, not to wait for a threshold of 200 mg/dL.

- Option 4: Restrict fluid intake to 500 mL per day to prevent fluid overload. A rigid fluid restriction of 500 mL per day is not a standard, evidence-based starting point for all patients with CKD stage 4. Fluid allowance is highly individualized and is calculated based on the client's 24-hour urine output plus an insensible loss allowance (typically 500-600 mL). Prescribing a flat restriction without this assessment could lead to dehydration and pre-renal injury or, conversely, may be insufficient for a patient who is still making a significant amount of urine. Volume status management is critical, but it requires a tailored approach based on daily weights, intake and output, and clinical assessment ^[4].

Integrating Symptom Burden and Self-Care
Effective management of hypertension is also foundational for enhancing the client's capacity for self-care. A high symptom burden in diabetic hemodialysis patients is directly associated with a lower level of self-care agency, a relationship that is mediated by the patient's level of comfort . By prioritizing interventions that control blood pressure and slow disease progression, the nurse helps reduce the physical symptoms and psychological distress that erode a patient's ability to manage their complex health regimen. This underscores that the priority action of blood pressure management is not an isolated task but a critical component of a holistic strategy to improve long-term clinical outcomes and the patient's ability to participate in their own care .